Identification and SAR for a selective, nonpeptidyl thrombin inhibitor
摘要:
A novel, nonpeptidyl thrombin inhibitor, L-636,619 (1), was identified via topological similarity searching over the Merck Corporate Sample Database. X-ray crystallographic studies determined the geometry for ligand binding to the enzyme. Chemical modification of the P1 and P3 segments of the ligand resulted in enhanced potency and improvement in the chemical stability of the lead. Analog 9 proved to be the most interesting lead from this structurally novel series. (C) 1998 Elsevier Science Ltd. ATI rights reserved.
Identification and SAR for a selective, nonpeptidyl thrombin inhibitor
摘要:
A novel, nonpeptidyl thrombin inhibitor, L-636,619 (1), was identified via topological similarity searching over the Merck Corporate Sample Database. X-ray crystallographic studies determined the geometry for ligand binding to the enzyme. Chemical modification of the P1 and P3 segments of the ligand resulted in enhanced potency and improvement in the chemical stability of the lead. Analog 9 proved to be the most interesting lead from this structurally novel series. (C) 1998 Elsevier Science Ltd. ATI rights reserved.
[EN] THROMBIN INHIBITORS<br/>[FR] INHIBITEURS DE THROMBINE
申请人:——
公开号:WO1998010763A1
公开(公告)日:1998-03-19
[EN] A compound which inhibits human thrombin and which has general structure (I) such as formula (a). [FR] On décrit un composé qui inhibe la thrombine chez l'homme et qui est représenté par la formule générale (I) telle que la formule (a).
Identification and SAR for a selective, nonpeptidyl thrombin inhibitor
作者:Adel M. Naylor-Olsen、Gerald S. Ponticello、S.Dale Lewis、Anne M. Mulichak、Zhonguo Chen、Charles N. Habecker、Brian T. Phillips、William M. Sanders、Thomas J. Tucker、Jules A. Shafer、Joseph P. Vacca
DOI:10.1016/s0960-894x(98)00296-0
日期:1998.7
A novel, nonpeptidyl thrombin inhibitor, L-636,619 (1), was identified via topological similarity searching over the Merck Corporate Sample Database. X-ray crystallographic studies determined the geometry for ligand binding to the enzyme. Chemical modification of the P1 and P3 segments of the ligand resulted in enhanced potency and improvement in the chemical stability of the lead. Analog 9 proved to be the most interesting lead from this structurally novel series. (C) 1998 Elsevier Science Ltd. ATI rights reserved.